Safety, toleration, and pharmacokinetics of intravenous azithromycin

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2577-2581

  Luke, David R ^a   Foulds, George ^a   Cohen, Sandra F ^b   Levy, Benjamin ^b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b Natl Medical Research Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ERYTHROMYCIN; MOTILIN; PLACEBO;

ABDOMINAL CRAMP; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; FLATULENCE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; HUMAN EXPERIMENT; HUNGER; INTRAVENOUS DRUG ADMINISTRATION; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029911053     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2577     Document Type: Article

References (19)

1. Barry, A. L., and R. N. Jones. 1988. Interpretative criteria for the agar diffusion susceptibility test with azithromycin. J. Antimicrob. Chemother. 22:637-641.
2. Barry, A. L., R. N. Jones, and C. Thornsberry. 1988. In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin. Antimicrob. Agents Chemother. 32:752-754.
3. Bergan, T., N. P. Jørgensen, W. Olszewski, and Y. Zhang. 1992. Azithromycin pharmacokinetics and penetration in lymph. Scand. J. Infect. Dis. 83:15-21.
4. Coates, P., R. Daniel, A. C. Houston, J. H. L. Antrobus, and T. Taylor. 1991. An open study to compare the pharmacokinetics, safety, and tolerability of a multiple-dose regimen of azithromycin in young and elderly volunteers. Eur. J. Clin. Microbiol. Infect. Dis. 10:850-852.
5. Foulds, G., R. M. Shepard, and R. B. Johnson. 1990. The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother. 25:73-82.
6. Friedman, C. R., and R. Soave. 1993. Intravenous azithromycin for cryptosporidiosis in AIDS, abstr. 190, p. 33A. In Program and abstracts of the 31st Infectious Diseases Society of America Annual Meeting.
7. Gardner, M. J., and R. A. Ronfeld. 1992. Interpretation/characterization of the pharmacokinetics of azithromycin in man, abstr. 407. In Program and abstracts of the 8th Mediterranean Congress on Chemotherapy.
8. Itoh, Z., M. Nakaya, T. Suzuki, H. Arai, and K. Wakabayashi. 1984. Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am. J. Physiol. 247:G688-G694.
9. Ives, D. V., R. B. Davis, and J. S. Currier. 1995. Impact of clarithromycin and azithromycin on patterns of treatment and survival among AIDS patients with disseminated Mycobacterium avium complex. AIDS 9:261-266.
10. Kissinger, P., R. Clark, A. Morse, and W. Brandon. 1995. Comparison of multiple drug therapy regimens for HIV-related disseminated Mycobacterium avium complex disease. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 9:133-137.
11. Lalak, N. J., and D. L. Morris. 1993. Azithromycin clinical pharmacokinetics. Clin. Pharmacokinet. 25:370-374.
12. Mitznegg, P., S. R. Bloom, N. Christofides, H. Besterman, S. Domschke, E. Wünsch, and L. Demling. 1976. Release of motilin in man. Scand. J. Gastroenterol. 11:53-56.
13. Peeters, T., G. Matthijs, I. Depoortere, T. Cachet, J. Hoogmartens, and G. Vantrappen. 1989. Erythromycin is a motilin receptor agonist. Am. J. Physiol. 257:G470-G474.
14. Peeters, T., G. Vantrappen, and J. Janssens. 1980. Fasting plasma motilin levels are related to the interdigestive motility complex. Gastroenterology 79:716-719.
15. Shepard, R. M., G. S. Duthu, R. A. Ferraina, and M. A. Mullins. 1991. High-performance liquid chromatographic assay with electrochemical detection for azithromycin in serum and tissues. J. Chromatogr. Biomed. Appl. 565:321-337.
16. Tomomasa, T., T. Kuroume, H. Arai, K. Wakabayashi, and A. Itoh. 1986. Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig. Dis. Sci. 31:157-161.
17. Whitman, M. S., and A. R. Tunkel. 1992. Azithromycin and clarithromycin: overview and comparison with erythromycin. Infect. Control Hosp. Epidemiol. 12:357-358.
18. You, C., W. Chey, and K. Lee. 1980. Studies on plasma motilin concentration and interdigestive motility of the duodenum in humans. Gastroenterology 79:62-66.
19. Zuckerman, J. M., and K. M. Kaye. 1995. The newer macrolides: azithromycin and clarithromycin. Infect. Dis. Clin. N. Am. 9:731-745.